Clinical significance of the cardio-ankle vascular index (CAVI) in hypertension

Current Hypertension Reviews

Volumn 6, Issue 4, 2010, Pages 251-253

  Kotani, Kazuhiko ^a   Miyamoto, Michiaki ^a   Taniguchi, Nobuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti hypertensive therapy; Atherosclerosis; Blood pressure; PWV

Indexed keywords

AMLODIPINE; CANDESARTAN; EFONIDIPINE; LOSARTAN; OLMESARTAN; TELMISARTAN;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; ECHOGRAPHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE WAVE;

EID: 79751476555     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340210793611659     Document Type: Article

References (21)

1. Tanizaki Y, Kiyohara Y, Kato I, et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000; 31: 2616-22.
2. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-15.
3. Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14: 278-86.
4. Liao D, Arnett DK, Tyroler HA, et al. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 1999; 34: 201-6.
5. Dernellis J, Panaretou M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension 2005; 45: 426-31.
6. Franklin SS. Arterial stiffness and hypertension: a two-way street? Hypertension 2005; 45: 349-51.
7. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-64.
8. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-7.
9. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41.
10. Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-22.
11. Imanishi R, Seto S, Toda G, et al. High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 2004; 27: 71-8.
12. Takaki A, Ogawa H, Wakeyama T, et al. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 2008; 31: 1347-55.
13. Yamashina A, Tomiyama H, Arai T, et al. Nomogram of the relation of brachial-ankle pulse wave velocity with blood pressure. Hypertens Res 2003; 26: 801-806.
14. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressureindependent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006; 13: 101-107.
15. Yambe T, Yoshizawa M, Saijo Y, et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother 2004; 58: S95-8.
16. Okura T, Watanabe S, Kurata M, et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res 2007; 30: 335-40.
17. Uehara G, Takeda H. Relative effects of telmisartan, candesartan and losartan on alleviating arterial stiffness in patients with hypertension complicated by diabetes mellitus: an evaluation using the cardio-ankle vascular index (CAVI). J Int Med Res 2008; 36: 1094-102.
18. Miyashita Y, Saiki A, Endo K, et al. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb 2009; 16: 621-6.
19. Sasaki H, Saiki A, Endo K, et al. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb 2009; 16: 568-75.
20. Uurtuya S, Kotani K, Taniguchi N, et al. Comparative study of atherosclerotic parameters in Mongolian and Japanese patients with hypertension and diabetes mellitus. J Atheroscler Thromb 2010; 17: 181-8.
21. Uurtuya S, Taniguchi N, Kotani K, et al. Comparative study of the cardio-ankle vascular index and ankle-brachial index between young Japanese and Mongolian subjects. Hypertens Res 2009; 32: 140-4.